tiprankstipranks
Precigen Secures $79M Financing for 2025 Launch
PremiumCompany AnnouncementsPrecigen Secures $79M Financing for 2025 Launch
2M ago
Stifel thinks Precigen stock set to rebound after capital secured, BLA submitted
Premium
The Fly
Stifel thinks Precigen stock set to rebound after capital secured, BLA submitted
2M ago
Precigen submits BLA with request for priority review to FDA for PRGN-2012
Premium
The Fly
Precigen submits BLA with request for priority review to FDA for PRGN-2012
2M ago
PGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsPGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
Precigen Regains Full Control of Technology Post Agreement Termination
Premium
Company Announcements
Precigen Regains Full Control of Technology Post Agreement Termination
5M ago
Precigen Aligns Executive Incentives with FDA Approval Goals
Premium
Company Announcements
Precigen Aligns Executive Incentives with FDA Approval Goals
6M ago
Precigen 35.3M share Spot Secondary priced at 85c
PremiumThe FlyPrecigen 35.3M share Spot Secondary priced at 85c
7M ago
Precigen to cut 20% of its workforce, pause all preclinical programs
Premium
The Fly
Precigen to cut 20% of its workforce, pause all preclinical programs
7M ago
Precigen Refocuses with Gene Therapy Launch and Stock Offering
Premium
Company Announcements
Precigen Refocuses with Gene Therapy Launch and Stock Offering
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100